SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-503094"
 

Search: onr:"swepub:oai:DiVA.org:uu-503094" > Individual net clin...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores

Hijazi, Ziad (author)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi
Lindbäck, Johan (author)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
Oldgren, Jonas, 1964- (author)
Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)
show more...
Benz, Alexander P. (author)
Populat Hlth Res Inst, Hamilton, ON, Canada.;Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Cardiol, Cardiol 1, Mainz, Germany.
Alexander, John H. (author)
Duke Clin Res Inst, Duke Med, Durham, NC USA.
Connolly, Stuart J. (author)
Populat Hlth Res Inst, Hamilton, ON, Canada.
Eikelboom, John W. (author)
Populat Hlth Res Inst, Hamilton, ON, Canada.
Granger, Christopher B. (author)
Duke Clin Res Inst, Duke Med, Durham, NC USA.
Lopes, Renato D. (author)
Duke Clin Res Inst, Duke Med, Durham, NC USA.
Siegbahn, Agneta, 1947- (author)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Klinisk kemi
Wallentin, Lars, 1943- (author)
Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)
show less...
 (creator_code:org_t)
Elsevier, 2023
2023
English.
In: American Heart Journal. - : Elsevier. - 0002-8703 .- 1097-6744. ; 261, s. 55-63
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BackgroundDecisions on stroke prevention strategies in patients with atrial fibrillation (AF) depend on the perceived risks of stroke and bleeding with different antithrombotic treatment strategies. The study objectives were to evaluate net clinical outcome with oral anticoagulation (OAC) for the individual patient with AF and to identify clinically relevant thresholds for OAC treatment.MethodsPatients with AF receiving OAC treatment in the randomized ARISTOTLE and RE-LY trials, with available biomarkers for calculation of ABC-AF scores at baseline, were included (n = 23,121). Observed 1-year risk on OAC was compared with predicted 1-year risk if the same patients would not have received OAC using the ABC-AF scores calibrated for aspirin. Net clinical outcome was defined as the sum of stroke and major bleeding risks.ResultsThe ratio between the 1-year incidence of major bleeding and stroke/systemic embolism events ranged from 1.4 to 10.6 according to different ABC-AF risk profiles. Net clinical outcome analyses showed that in patients with an ABC-AF-stroke risk >1% per year on OAC (>3% without OAC), treatment with OAC consistently provides larger net clinical benefit than no-OAC treatment. In patients with an ABC-AF-stroke risk <1.0% per year on OAC (<3% without OAC) an individualized balancing of risks regarding OAC or no-OAC treatment is needed.ConclusionsIn patients with AF, the ABC-AF risk scores allow an individual and continuous estimate of the balance between benefits and risks with OAC treatment. This precision medicine tool therefore seems useful as decision support and visualizes the net clinical benefit or harm with OAC treatment (http://www.abc-score.com/abcaf/).Clinical Trial RegistrationClinicalTrials.gov identifier NCT00412984 (ARISTOTLE) and NCT00262600 (RE-LY).

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view